MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD
- PMID: 34101492
- DOI: 10.1089/dna.2021.0330
MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD
Abstract
NAD is mainly biosynthesized by the enzymatic action of nicotinamide phosphoribosyltransferase (NAMPT) through the salvage pathway. NAD is indispensable for the proper function and metabolism of all living cells, including cancer cells. Our previous researches revealed that inhibition of NAMPT by miRNA (miR) could suppress NAD levels and thereby hinder the growth and promotion of breast cancer (BC). Therefore, the current study was undertaken to investigate the inhibitory effects of miR-613 on NAMPT and BC cells' survival. Bioinformatics analysis and luciferase reporter assay confirmed that NAMPT 3'-untranslated region is a direct target for miR-613. The expression of miR-613 was noticed to be significantly decreased in both clinical tissue samples and BC cells by real-time PCR. Following transfection with miR-613 mimic, the expression of miR-613 was elevated in the BC cells leading to inhibition of NAMPT expression at both mRNA and protein level as measured by real-time PCR and western blotting, respectively. Inhibition of NAMPT led to a remarkable reduction in the concentration of NAD in the BC cells. The transfection also declined cell viability roughly 40% in MD Anderson-Metastatic Breast-231 (MDA-MB-231) cells. Consistently, the apoptosis rate was remarkably increased, around 65% in these cells as assayed by labeling the cells with Annexin V-fluorescein isothiocyanate (FITC) and Propidium Iodide. Targeting the NAMPT-mediated NAD salvage pathway by miR-613 is a novel approach for managing BC, which is worth further investigation.
Keywords: apoptosis; breast cancer; miR-613; miRNA; nicotinamide phosphoribosyltransferase.
Similar articles
-
MicroRNA-26b Reduces Cell Viability by Inhibition of Nicotinamide Phosphoribosyltransferase in Breast Cancer Cells.DNA Cell Biol. 2022 Aug;41(8):735-741. doi: 10.1089/dna.2022.0214. Epub 2022 Jul 6. DNA Cell Biol. 2022. PMID: 35792597
-
Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin.BMC Cancer. 2019 Nov 1;19(1):1027. doi: 10.1186/s12885-019-6221-0. BMC Cancer. 2019. PMID: 31675930 Free PMC article.
-
Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.Gene. 2018 Oct 5;673:149-158. doi: 10.1016/j.gene.2018.06.021. Epub 2018 Jun 8. Gene. 2018. PMID: 29886033
-
Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.Expert Rev Anticancer Ther. 2016 Aug;16(8):827-38. doi: 10.1080/14737140.2016.1190649. Epub 2016 Jul 5. Expert Rev Anticancer Ther. 2016. PMID: 27186719 Review.
-
Physiological and pathophysiological roles of NAMPT and NAD metabolism.Nat Rev Endocrinol. 2015 Sep;11(9):535-46. doi: 10.1038/nrendo.2015.117. Epub 2015 Jul 28. Nat Rev Endocrinol. 2015. PMID: 26215259 Review.
Cited by
-
Supplementation with NAD+ and its precursors: A rescue of female reproductive diseases.Biochem Biophys Rep. 2024 Apr 23;38:101715. doi: 10.1016/j.bbrep.2024.101715. eCollection 2024 Jul. Biochem Biophys Rep. 2024. PMID: 38698835 Free PMC article. Review.
-
MicroRNA-372 acts as a double-edged sword in human cancers.Heliyon. 2023 May 9;9(5):e15991. doi: 10.1016/j.heliyon.2023.e15991. eCollection 2023 May. Heliyon. 2023. PMID: 37251909 Free PMC article. Review.
-
Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches.Cancers (Basel). 2022 Apr 19;14(9):2059. doi: 10.3390/cancers14092059. Cancers (Basel). 2022. PMID: 35565188 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous